Gastrointestinal Cancer: Selection of Clinically Relevant Drug-Induced Toxicities Encountered in Gastrointestinal Cancer Treatment

作者: Julie Bogaert , Pieter-Jan Cuyle , Eric Van Cutsem

DOI: 10.1007/978-0-85729-787-7_4

关键词:

摘要: The chemotherapeutic options have increased dramatically in patients with gastrointestinal cancer and led to an improved outcome. With this, in-depth understanding of the side effects chemotherapy is becoming increasingly important order minimize negative impact use these agents. Chemotherapeutic agents a long list potential effects. In this chapter, we focus specifically on some more common and/or relevant challenging related frequently used cancer. fluoropyrimidines may cause cardiac toxicity, most angina-like chest pain. knowledge catabolism fluorouracil has possibility testing for dihydropyrimidine dehydrogenase (DPD) avoid serious fluorouracil-related toxicity DPD deficiency. Oxaliplatin-induced neurotoxicity probably clinical problem associated administration oxaliplatin. increasing oxaliplatin, hypersensitivity reactions are reported become practice. introduction targeted colorectal also specific problems: anti-VEGF-related effects, which perforation, although relatively rare, very patient, anti-EGFR-related including skin rash, hypomagnesemia, allergic reactions, common. Understanding underlying causes, mechanisms, risk factors, developing treatment guidelines made often acceptable many patients. However, side-effect profile always be balanced against activity benefit anticancer

参考文章(53)
Thomas J. George, Kourtney D. Laplant, James W. Lynch, Julia L. Close, Sarah N. George, Arlene B. Davis, Edmund O. Walden, Charles E. Riggs, Managing cetuximab hypersensitivity-infusion reactions: incidence, risk factors, prevention, and retreatment. The journal of supportive oncology. ,vol. 8, pp. 72- 77 ,(2010)
Andre Van Kuilenburg, Rutger Meinsma, Lida Zoetekouw, Albert Van Gennip, High prevalence of the IVS14+1G>A mutation in the dihydropyrimidine dehydrogenase gene of patients with severe 5-fluorouracil-associated toxicity Pharmacogenetics. ,vol. 12, pp. 555- 558 ,(2002) , 10.1097/00008571-200210000-00007
M C Etienne, J L Lagrange, O Dassonville, R Fleming, A Thyss, N Renée, M Schneider, F Demard, G Milano, Population study of dihydropyrimidine dehydrogenase in cancer patients. Journal of Clinical Oncology. ,vol. 12, pp. 2248- 2253 ,(1994) , 10.1200/JCO.1994.12.11.2248
Benoit You, Eric X. Chen, Anti-EGFR monoclonal antibodies for treatment of colorectal cancers: development of cetuximab and panitumumab. The Journal of Clinical Pharmacology. ,vol. 52, pp. 128- 155 ,(2012) , 10.1177/0091270010395940
E. Giorgio, C. Caroti, F. Mattioli, V. Uliana, M. I. Parodi, Mauro D’Amico, C. Fucile, V. Marini, F. Forzano, G. Cassola, A. Martelli, F. Faravelli, E. Di Maria, Severe fluoropyrimidine-related toxicity: clinical implications of DPYD analysis and UH2/U ratio evaluation. Cancer Chemotherapy and Pharmacology. ,vol. 68, pp. 1355- 1361 ,(2011) , 10.1007/S00280-011-1709-6
Christos Kosmas, Manolis S. Kallistratos, Petros Kopterides, John Syrios, Helias Skopelitis, Nicolaos Mylonakis, Athanasios Karabelis, Nicolas Tsavaris, Cardiotoxicity of fluoropyrimidines in different schedules of administration: a prospective study Journal of Cancer Research and Clinical Oncology. ,vol. 134, pp. 75- 82 ,(2007) , 10.1007/S00432-007-0250-9
Siegfried Segaert, Gabriela Chiritescu, Liesbeth Lemmens, Kristien Dumon, Eric Van Cutsem, Sabine Tejpar, Skin toxicities of targeted therapies European Journal of Cancer. ,vol. 45, pp. 295- 308 ,(2009) , 10.1016/S0959-8049(09)70044-9
Hong-Hee Won, Jeeyun Lee, Joon Oh Park, Young Suk Park, Ho Yeong Lim, Won Ki Kang, Jong-Won Kim, Soo-Youn Lee, Se Hoon Park, Polymorphic markers associated with severe oxaliplatin-induced, chronic peripheral neuropathy in colon cancer patients. Cancer. ,vol. 118, pp. 2828- 2836 ,(2012) , 10.1002/CNCR.26614
Andrew Weickhardt, Keith Wells, Wells Messersmith, Oxaliplatin-Induced Neuropathy in Colorectal Cancer Journal of Oncology. ,vol. 2011, pp. 201593- 201593 ,(2011) , 10.1155/2011/201593
Maudy Walraven, Petronella O. Witteveen, Martijn P. J. Lolkema, R. van Hillegersberg, Emile E. Voest, H. M. W. Verheul, Antiangiogenic tyrosine kinase inhibition related gastrointestinal perforations: a case report and literature review. Angiogenesis. ,vol. 14, pp. 135- 141 ,(2011) , 10.1007/S10456-010-9197-6